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 Abstract 
The study of aerosol exposure and dosimetry measurements and related quantitation of 
health effects are important to the understanding of the consequences of air pollution, and 
are discussed widely in the scientific literature. During the last 10 years the need to 
correlate aerosol exposure and biological effects has become especially important due to 
rapid development of a new, revolutionary industry – nanotechnology.  Nanoproduct 
commerce is predicted to top $1 trillion by 2015.  Quantitative assessment of aerosol 
particle behavior in air and in lung deposition, and dosimetry in different parts of the 
lung, particularly for nanoaerosols, remains poor despite several decades of study.  Direct 
measurements on humans are still needed in order to validate the hollow cast, animal 
studies, and lung deposition modeling. We discuss here the use of nanoscale radon decay 
products as an experimental tool in the study of local deposition and lung dosimetry for 
nanoaerosols. The issue of the safe use of radon progeny in such measurements is 
discussed based on a comparison of measured exposure in 3 settings: general population, 
miners, and in a human experiment conducted at the Paul Scherer Institute (PSI) in 
Switzerland. One of the properties of radon progeny is that they consist partly of 1 nm 
radioactive particles called unattached activity; having extremely small size and high 
diffusion coefficients, these particles can be potentially useful as radioactive tracers in 
the study of nanometer-sized aerosols.  We present a theoretical and experimental study 
of the correlation between the unattached activity and aerosol particle surface area, 
together with a description of its calibration and method for measurement of the 
unattached fraction.   
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Introduction 
The health effects from aerosols in air pollution are discussed widely in the scientific 
literature. During the last 10 years the need to understand the relationships between 
aerosol exposure and biological effects has beco me specially important due to rapid 
development of new, revolutionary industry – nanotechnology. Commerce in 
nanoproducts could top $1 trillion by 2015 (Nanotechnology Now, July 17, 2007).  
 
Understanding of the relationship between aerosol concentration in the breathing air and 
particle deposition in different portions of the lung remains poor, in spite of several 
decades of research. Without direct validation through measurement of aerosol deposition 
and dose, uncertainty in estimates from inhalation models will persist.  
 
According to the Strategic Plan for NIOSH Nanotechnology Research (NIOSH, 2005) 
there are many gaps in our knowledge of aerosols in the nanometer range, which we need 
to fill in order to improve risk assessment and dosimetry of nanoaerosols, including: 
 
• Measurement studies of nanoparticles in the workplace. 
• Particle surface area as a dose metric. 
• Dosimetry and risk assessment. 
• Evaluation of pulmonary deposition and translocation of nanomaterials. 
• Filter efficiency of typical respirators for nanoscale particles. 
• Evaluation respirator performance. 
• Development of computer-aided face fit evaluation methods. 
 
One experimental approach that addresses these problems uses safe doses of radioactive 
tracer particles: after particles are inhaled, their spatial distribution in the lung is 
determined through two- and possibly three-dimensional spectrometric imaging. In recent 
 3
years published literature on the effectiveness of risks associated with using radioactive 
markers in human imaging has matured to the point where reliable and safe protocols 
have been devised for their measurement. 
 
As mentioned by Oberdörster (Oberdörster, et al, 2005) it is not clear if there are 
significant human exposures to airborne-engineered carbon nanotubes or C60 fullerene 
particles. This is of concern, because, for example, at the very low mass concentration of 
10 µg/m3 of unit density 20 nm particles, the number concentration is greater than 106 
particles/cm3. At this concentration, what will is the particle surface dose delivered per 
cm2 to different lung tissue? Animal studies using ultrafine and nanometer-sized aerosols 
showed that such particles induced significant pulmonary inflammatory responses as well 
as effects in extrapulmonary organs (Oberdörster, 2005).  
 
Yet, without direct measurements of response in humans with accurate dosimetry we 
cannot make conclusive estimates of the risks. Examples of the safe use of radioisotopes 
to label aerosol particles for human inhalation studies are presented in the literature.  In 
one study (Philipson et al. 1996) ten healthy males inhaled monodisperse Teflon particles 
with geometric diameter 3.6 µm labeled with 195Au. Depending on the detector used, they 
found the clearance half-life averaged 740 and 680 days for the NaI and the Ge detectors, 
respectively.  In a second study (Brown et al, 2000), ultrafine carbon particle aggregates 
labeled with 99Tc aerosols having diameters ranging from 50 to 150 nm were developed 
for use in human inhalation studies. In another study (Kim, et al., 2000) the “respiratory 
dose” of ultrafine particles (40, 60, 80, and 100 nm in diameter) in healthy young adults 
was measured using a novel serial bolus-delivery method.  More recently, a study on the 
retention of ultrafine 35 and 100 nm particles in human lungs (Svartengen, et al., 2005), 
mean retention values were observed to be close to 100%, and no evidence of significant 
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translocation to the circulatory system from the lungs was observed. Authors suggest that 
contradictory results from earlier studies might be due to unstable radiolabeling. 
 
A number of studies on the exposure of ultrafine and, especially, nanometer aerosols 
(Donaldson et al. 1998; Oberdörster et al. 2005), have indicated that health effects 
associated with low-solubility inhaled particles may be more appropriately associated 
with particle surface area than with mass concentration. Such data on the correlation 
between number, surface area and mass concentration are needed for exposure 
investigations.  
 
The use of particle surface area as a dose metric for nanoaerosols is discussed in many 
reports: NIOSH (2006), Royal Society (2004), NIOSH (2005), NIOSH (2006a), Aitken et 
al. (2004), DEFRA (2007), SCENIHR (2006), Renn and Roco (2006), ASCC (2006). 
 
It has been mentioned that particle surface area might provide the most suitable criterion 
for assessing inhalation exposure. Currently however, there is a need to develop and 
expand methods available by which particle surface area can be assessed in the 
workplace. The main concern is with free nanoaerosols that are more available for 
absorption and distribution within the body. Investigators found that when lung burdens 
and clearance rates were expressed as a function of the surface area, there was a much 
closer correlation with biological responses, ASCC (2006), 
 
The special importance of the surface area of nanoparticles in the study of the risk 
assessment is discussed in (Maynard, 2007) by comparing the three characteristics: 
particle number, surface area, and mass concentration. 
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Another important issue in the safety of people working with nanomaterials is the 
efficiency of respirators, discussed in many reports: NIOSH (2006b), Aitken (2004), 
Renn and Roco (2006). It is well known that the determining factor governing the 
effectiveness of respiratory protective equipment (RPE) is not absolute penetration 
through the filter, but rather face-seal leakage causing particles to bypass the device.  
ASCC (2006) 
 
In this paper we discuss a new approach to the measurement of aerosol surface area 
concentration based on the rate of deposition of the unattached activity of radon progeny 
on aerosol particles. The correlation, results of calculation, and the assessment of the 
sensitivity of this method will be presented. 
 
Approach: Safety of radioactive markers in aerosol exposure study.
We may assume that a radioactive marker is safe in an experiment with human subjects if 
the radiation exposure is negligible relative to the subjects’ background exposures.  The 
following three scenarios of exposure to radon and its decay products put this into 
perspective: 
1. A general population with average background radon concentration of 20-80 Bq/m
3
; 
and lifetime exposure duration of 600,000 hours (70 years); 
2. Miners, with the permissible concentration 1100 Bq/m
3
; and exposure duration of 
60,000 hours (30 work-years); 
3. The human exposure experiment in Paul Scherer Institute (PSI), Switzerland 
(Butterweg et al., 2001), of 20,000 Bq/m3 and duration of exposure 0.5 hours. 
A comparison of these three cases shows that radiation exposure in the human 
experiment was less than 1/1000th the magnitude of the lifetime background exposure. 
From a radioactive exposure point of view, the PSI experiment was safe. 
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Nonetheless, such human experiments need radiation and environmental health and 
safety reviews.  Also, the type of radiation, half-life, clearance, and the particle size of 
the markers should be taken into account.  The chemical characteristics and the size 
distribution of the non-radioactive aerosol under study are also important in assessing the 
safety of human exposure experiments.  The experiment at the PSI, mentioned above, 
was conducted after a human subjects internal review board (IRB) approval by the 
“Uberregionale ehtische Kommision fur klinische Forschung der Schweizerischen 
Akademie der medizinischen Wissenschaften” was granted (Butterweck, et al 2001). 
 
In the above study, seven nose-breathing and eleven mouth-breathing volunteers were 
exposed for 30 min in a PSI walk-in radon chamber with the unattached and attached 
218Po concentration of 3800 and 200 Bq/m3, respectively.  For these measurements, a 
whole-body counter at the PSI, equipped with two additional 15.4 cm diameter by 5.1 cm 
thickness detectors, was employed for the measurement of activity located in the head of 
the volunteers. To reduce the activity deposited on the surface of the volunteer’s body, 
dust protection clothing including head and foot covering were used.  No significant 
deviation between measured activities and predictions by the ICRP Publication 66 
Human Respiratory Tract Model (ICRP, 1994) was found.  The expected fast particle 
transport from nasal passages, larynx, and mouth to the GI tract was not found. The 
explanation may be that a substantial fraction of deposited activity with diameter of 1 nm 
is bound to lung tissue.  The most important aspect of this study is that from a radiation 
safety point of view it is possible to provide similar human experiments in laboratory 
conditions, after radiation safety and IRB approval.  
 
Similar studies (Ruzer, et al 2004) were conducted with miners who during their normal 
work activities were exposed to much lower concentrations of radon, much higher 
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gamma-background, and simple instrumentation that quantified post-exposure gamma 
emissions from the chest of the subjects.  
 
Characteristics of Radon progeny 
The presence of radon and its decay products in the air is due to the abundance in the 
earth of unstable heavy metals (radioactive elements at the end of the periodic table). One 
of them, uranium, undergoes a long series of transformations to yield radium. The chain 
of radioactive decay continues beyond radium to generate radon, a radioactive noble gas.  
Due to its inert chemical properties, radon does not bind completely to surficial soils in 
the earth or stay in water, but enters the atmosphere as a gas.  
 
The elements following radon in the radioactive decay chain - isotopes of polonium, 
bismuth and lead, atom-sized radionuclides, may attach to aerosol particles to become 
radioactive aerosols or exist in unattached forms in the air.  Eventually, they may be 
deposited in the lung and cause irradiation of the lung tissue.  The specific biological 
consequences depend upon the dose of radioactive aerosols which in turn depends on 
physiological characteristics including human breathing rates, especially changes with 
physical activity as well as the amount of the radium in the soil and radon and its decay 
products in the air, and atmospheric conditions both in the open air, dwellings and the 
underground environment. 
 
Figure 1 presents diagrams of the radioactive families yielded by 226Ra.  Clearly, the 
decay products represent a very complicated system consisting of a series of radioactive 
elements and various types of decay (alpha-, beta-, and gamma).  In terms of the radiation 
safety, the most important radionuclides are alpha-emitters because the alpha particles 
have the greatest ionization density (Linear Energy Transfer - LET).  Given identical 
absorbed energy, the biological effect of alpha-particles is thought to be 20 times greater 
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than the corresponding effect of beta-particles and gamma-radiation (that is, the "quality 
coefficient" for alpha particles is 20).  However, due to low particle penetration through 
human tissue, it is impossible to externally measure the alpha-activity of aerosols 
deposited in the lung of a living subject.  As a result this alpha-radioactivity is typically 
measured in the air and the absorbed dose to the lungs is then calculated according to the 
known concentration, breathing rate and coefficient of deposition in the lungs (which is 
not accurate). 
 
Assessment of particle deposition in lungs.  
Ruzer (1964, 1970) presented another, more precise, opportunity for assessment of the 
alpha-dose to the lung from radon progeny.  It was based on the derived correlation 
between the alpha-dose and gamma-activity of radon progeny measured directly from the 
lung. This possibility was studied first on animals, then in model experiments, and 
finally, after certification from the Soviet Ministry of Health, on hundreds of miners in 
the former Soviet Republics of Tajikistan, Uzbekistan, and Kazakhstan.  It was shown for 
concentrations in the range of maximum permissible in mines, gamma-activity of radon 
progeny in the lung can be measured directly by means of a simple technique, such as the 
use of NaI (Tl) crystal detectors with standard lead shielding. 
 
This approach of direct measurement of the natural marker such as radon progeny 
can also be used for the assessment of deposition of non-radioactive aerosols, particularly 
nanometer aerosols, in the lung. 
 The formula for gamma-activity Aγ  is: 
   
 Aγ  = a v k (qb + qc) (1), 
where:  
a, a proportionality coefficient, 
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v, the volumetric breathing rate, 
k, the lung deposition coefficient, 
qb and qc, the concentrations of the 214Pb (RaB) and 214Bi (RaC) correspondingly. 
 
Based on (1) these results yield values for the product vk, which has been termed 
“Filtration Ability of Lungs” (FAL) (Ruzer et al., 2004), where: 
 
 FAL = vk =  Aγ /a q (2) 
where:  
q = qb + qc. 
 
FAL is an important breathing parameter reflecting the gross particle removing behavior of the 
respiratory system. It is a “bridge” between the quantity of aerosols in the air and in the lung for 
different physical activities.  
 
Measurements were performed without disturbing the working conditions for three occupational 
groups: drillers, auxiliary drillers and inspection personnel, totaling approximately 100 workers. 
The average, standard error, and the median values for a total of 297 air samples and 391 lung 
measurements are shown in Table 1 (Ruzer et al., 1995). From the average (arithmetic mean) and 
median values for each group, the air concentrations and chest gamma activity are estimated to 
be distributed log-normally with a geometric standard deviation of 2.0 to 2.5. 
 
The measurements were also carried out in a non-uranium mine in Tajikistan (former 
USSR) with a special instrument having two probes, (Antipin et al, 1978), one - for lung 
gamma-activity measurement, and the other - for air alpha-activity measurement (Figure 
2). 
 10
As we mentioned before, these experiments, conducted in specific underground 
conditions with a high gamma-background, were provided with simple, portable 
instrumentation. Therefore it was difficult to study the detailed distribution of activity in 
the lung. The successful measurements made in this study under rugged mining 
conditions illustrate the possibilities for using radon progeny as a tracer in the study of 
aerosol distribution in lung.  This method would be particularly suited for use in the 
nanometer range, under laboratory conditions, where the background is low, and 
instrumentation is much more sensitive, similar to the studies conducted at PSI.  This 
approach could be used to map aerosol dose to the lung because it can provide graphic 
information on where these particles of different sizes are deposited in the respiratory 
system. 
Thus, the approach is to use radon progeny as a marker at safe doses in the study 
of deposition of non-radioactive nanoaerosols in the human body. The proposed radiation 
dose during a human experiment will be negligible in comparison with the natural 
background exposure over time.  This is consistent with the use of radiological tracers for 
other medical research. For human experiments we propose using a generator of 
unattached fraction of radon progeny.  This could be a small environmental chamber such 
as used in the Swiss research (Butterweck, et al 2001), or using a respirator mask 
exposure apparatus attached to a small chamber. Both radon and monodisperse aerosols 
of known size and morphology will be injected into the chamber under controlled 
conditions.  
 
In terms of radioactive safety, when properly handled, the gamma-activity of radium is 
negligible. Through radioactive decay, radium produces radon (222Rn), which in turn will 
produce atoms of 218Po. Once it is released into the air, about 10-12 molecules of air 
constituents naturally diffuse onto and surround the 218Po atom. These clusters are about 
1 nm in diameter and have a diffusion coefficient of ~ 0.06 cm2s-1.  They are called 
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unattached activity of radon progeny.  Again through natural diffusion processes, these 
Rn progeny deposit on particles coexisting in the air ranging in size from nanometers to 
micrometers.   
 
Controlled experiments where nanometer (or larger) sized aerosols of known diameter 
are radiolabeled through natural attachment to unattached activity (e.g., becoming 
“attached activity”) can be used to trace aerosol lung or surface deposition behavior.  To 
do this, a size-characterized monodisperse aerosol is inserted into an exposure chamber 
containing particle-filtered air.  Rn progeny are also inserted into the chamber at a 
controlled or known rate. .  By measuring the unattached fraction in the air we can assess 
the particle surface area of aerosols, see (Ruzer and Apte, 2005, Ruzer, 2008), and for 
monodisperse aerosols consequently we assess the particle concentration.  The ratio 
between particles attached to the nanoparticle activity and the nanoaerosol particle 
concentration itself will be known.  After the nanometer aerosol (labeled with radon 
progeny) is inhaled into the lungs, the nanometer particles will be locally deposited 
according to their size depending on some breathing parameters (volume breathing rate, 
humidity and temperature).  
 
Until now, experimental data on nanoaerosol deposition in human lungs have not been 
available. For larger sized aerosols mostly bulk deposition data are available, based on 
the difference in concentration in exhaled and inhaled air. However, it is well known that 
biological effects depend on local deposition. 
 
After exposure, the local gamma emission distribution in the lung can be measured using 
a gamma-spectrometer, with the local activity being proportional to the aerosol 
deposition (dose).  In addition, it may be possible to use SPECT scanning to provide a 
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more precise spatial resolution of particle deposition and local dosing (Piai, et al., 2004, 
Kao, et al., 1997). 
 
As with all such radiotracer studies, the protocol must meet the approval of an IRB and 
radiological screening review.  In these experiments, as in other studies, when radiation is 
used as a tool, for example, in using radiation in the study of Alzheimer disease, we have 
to compare the risk with benefit. The use of such experiments will enable us to close the 
gaps in our knowledge. Quantitative assessment of the local deposition of aerosol is at 
the core of aerosol, and particularly nanoaerosol exposure and risk assessment. So, our 
goal will be to find the safest possible and most appropriate marker. 
 
Radon progeny are attractive as a marker for several reasons: 
1. Radon and its progeny belong to the natural background of radioactivity to which the 
general population is exposed during their lifetime. Therefore it is easy to assess the 
additional risks due to its use by the methods proposed. 
 2. Part of radon progeny, called “unattached activity,” are 1 nm sized particles with 
diffusion coefficient close to 0.06 cm2 s-1 (a size that attaches readily to nanoaerosols), 
which make it very attractive as a marker for nanoaerosols with a built-in signal. 
3.  Radon decay products are easy to generate. 
4.  Radon decay products are short-lived nuclei. 
 
Direct measurement on humans is needed in order to validate the hollow cast, animal 
studies, and modeling. From our point of view, this kind of study will be strategically 
important in nanoaerosol dosimetry and risk assessment. And it will partially close one of 
the many gaps in our understanding of nanoaerosol exposure. 
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The first step of this study should be human experiments with monodisperse spherical 
nanoparticles.  In the case of non-spherical particles, typically found in aerosol studies, 
we should use the term “equivalent diameter,” i.e. the diameter of a monodisperse aerosol 
with the same local deposition as the aerosol of interest.  Study of polydisperse aerosols 
adds complexity that can be resolved after the monodisperse aerosol lung deposition 
characterization across a broad nanometer size range is completed. 
 
Respirator efficiency 
Another substantial gap in our assessment of the exposure to nanoparticles is assessment 
of the true respirator efficiency. Direct measurement of radon progeny presents such an 
opportunity. It is well recognized that the determining factor in efficiency of respiratory 
protection equipment (RPE) against particulate challenges is not absolute penetration 
through the filter but rather face-seal leakage that bypasses the device. Face seal leakage 
is dependent on many factors including the fit of the mask to the face, duration of 
wearing, work activity, etc. (Aitken et al.  2004) 
 
Experiments on true respirator efficiency were provided in mines (Ruzer et al, 1995). 
Using direct measurement, the activity of radon progeny in the lung will be possible to 
assess the true respirator efficiency.  Let us denote:  
A0 – the measured activity in the lung without respirator;  
A – the measured activity in the lung with respirator. 
 
The true efficiency of the respirator is 
(A / A0) 100%, 
 
and the leakage through the respirator is 
[1 - (A / A0)] 100%. 
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In the Ruzer et al. study (1995), the true efficiency was found to be from 67 to 95% for 
aerosol in mines depending upon the individual’s training and type of work.  In order to 
assess the true efficiency of respirators for aerosols in the nanometer size range it is 
necessary to quantify the dose of these particles that reach the respiratory tract. 
 
Radon progeny as a tool in the assessment of particle surface area. 
As discussed above, one very important property of radon decay is that after radon decay, 
the newly formed atom of Po forms clusters that are useful as markers in studies of 
properties of non-radioactive aerosols.  Figure 3 depicts the basic processes of radon 
decay producing “unattached” and “aerosol attached” activities. According to this figure 
there should be some correlation between unattached activity and aerosol concentration.  
In other words, the smaller the aerosol concentration, the bigger will be the unattached 
activity and vise versa.  In quantitative terms, the unattached fraction of radon progeny 
can be used as a measure of aerosol particle concentration. This is the basis for the 
approach proposed in (Ruzer, 1964) for measuring very small aerosol concentrations.  
 
Below, we present the details and calibration procedure for unattached fraction 
measurement. .   
 
Method and calibration procedure. 
The method and calibration procedure for measurement of radon progeny unattached 
fraction is presented in Ruzer and Sextro (1997).  The equipment for calibration and 
measurement of unattached and attached radon progeny consists of:  
1. a chamber with regulated concentration of the unattached fraction of radon decay 
products in the range from 0, to close to 0.95-1.0 (note that a high aerosol 
concentration, > 106 particles/cm3, creates surface for diffusion of nearly all 
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unattached fraction, while a very low aerosol concentration will remove almost 
none of the attached fraction); 
2. an alpha-spectrometer; 
3. a set of diffusion batteries (diffusion batteries composed of wire screen can be used for 
collecting aerosol particles in the ultrafine and nanometer range  (Ruzer, Sextro, 
1997); 
4. an air Pump with regulated flow rate; and, 
5. high collection efficiency (99.999% for particle sizes < 1000 nm) gravimetric air 
filters. 
 
The calibration procedure consists of the following measurements: 
1.  e1, e2 - deposition coefficients of the unattached and attached radon progeny in 
diffusion battery, respectively; 
2.  e3, e4 - detection efficiencies of the unattached and attached radon progeny deposited 
in diffusion battery, respectively; 
3.  e - detection efficiencies of the summary (unattached and attached radon progeny) 
airborne activity on the filter.   
The procedure for measurement of the unattached fraction of radon progeny consists of 
measuring the activity of radon progeny inside the diffusion battery, in the diffusing 
battery backing filter, and in the open filter. 
 The unattached fraction of radon progeny, f, can be calculated as a ratio of the 
unattached (qu ) and sum [(qu +qa), unattached +attached] concentration according to the 
formula (Ruzer and Sextro, 1997): 
 
f = qu/[(qu+qa) = [eNdb(1-e2)-e2e4Nbf]/Nof[e1e3(1-e2)-e2e4(1-e1)], (3)  
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where Ndb, Nbf, and Nof - are measured activity in the diffusion battery, backing filter and 
open filter respectively.   
 
A summary of the results for this approach is presented in Figure 4, which shows the 
measurement of unattached concentration of 218Po relative to particle surface area 
concentration in the range of 0.3 to 2.1 µm, made with monodisperse latex aerosols of 
different sizes and concentrations (Dokukina and Ruzer, 1976).  In each case, the 
measured aerosol concentration was converted to the aerosol surface area concentration. 
These results suggest that for aerosols in the size range covered by this calibration, 0.3 to 
2.1 µm in diameter, the particle surface area concentration is in the corresponding range 
from 10-5 to 0.3 cm-1, and is related to the unattached fraction of 218Po, f.   The calibration 
procedure used is for monodisperse spherical particles, from which the surface area can 
be directly calculated.  In practice, for non-spherical and polydisperse aerosols an 
"equivalent surface area" should be used, which is the surface area of a spherical aerosol 
having the same diffusion deposition property as the real aerosol. Under actual 
measurement conditions (e.g. in a building or in a mine), the only measurements 
necessary to determine the unattached fraction (and to infer the average aerosol surface 
area) are those described above - a diffusion battery followed by a backing filter and an 
open face filter operated in parallel.  The alpha activity from 218Po on each of these three 
collectors is then measured and used with appropriate calibration factors to yield the 
unattached fraction. 
 
It has been shown (Ruzer and Apte, 2005, Ruzer, 2008 ) that the direct correlation 
between the unattached fraction of radon progeny 218Po and surface area of aerosols is in 
the nanometer range of (1 – 100 nm) is presented in the form of: 
     
 S  = (λA/β) [(1/f)-1] (4), 
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where: 
λA = decay constant of 218Po; 
β = v/4 ~ 4300 cm s-1;  
v = root mean square speed of molecules of radon decay products under standard 
conditions 
 
Results of these calculations, provided according equation (4) are shown in Figure 5 for 
218Po. 
Calculations were provided for the conditions where: 
r = 1, 5, 10, 20, 50, 75, 100, and 500 nm; and, 
f  = 0.99, 0.98, 0.97, 0.95, 0.92, 0.90, 0.85, 0.80, 0.75, 0.70, 0.65, 0.60, 0.55, 0.50, 0.45, 
0.40, 0.30, 0.25, 0.20, 0.15, 0.10, and 0.05.  
Results of calculation of the correlation of particle surface area S and unattached fraction 
f presented in Figure 6 
 
Results of the calculation showed that: 
 
1. For a constant unattached fraction, f, aerosol particles surface area, practically 
speaking, (in the range of measurements errors) does not depend on particle size in 
the nanometer range from 2 nm to 100 nm in diameter. 
2. The presented idea for assessment of the surface area will work for polydisperse 
nanometer sized particles. 
3. This method will be not sensitive to very small individual particles, because its 
contribution to the general surface area is proportional to the square of their diameter. 
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DISCUSSION AND CONCLUSIONS. 
The problem of aerosol deposition and lung dosimetry is very complicated. First, it is still 
very difficult to measure the particle size distribution of aerosol particles in the breathing 
zone of humans.  But, even if such data were available, the behavior of aerosol particles 
according to aerosol size spectra in different parts inside the lung is difficult to predict 
with high accuracy due to humidity, temperature, lung morphology, and other factors. 
Therefore, direct measurement of lung deposition parameters is still needed in order to 
validate the results of modeling. We have discussed the potential use of radon progeny as 
a radioactive marker, which can be used as an experimental tool in measurement of local 
deposition parameters and dosimetry of nanoaerosols. 
 
The first problem faced in using radioactive markers is that of safety.  We discuss three 
settings of human exposure experiments using radon decay products.  It is clear from the 
comparison, with careful controls, that the risk of such experiments is minimal. The 
benefits from gaining information on lung deposition and dosimetry will be extremely 
valuable.  Inter-species variability in respiratory system morphology and physiology is so 
great that similar data will be impossible to obtain in animal experiments. 
 
Review of literature on environmental health in the new rapidly developing 
nanotechnology industry shows that problem of exposure has not been adequately 
assessed (Oberdörster, 2005). Worker health and safety is of initial concern as 
occupational groups are likely to be among the first to be exposed to elevated 
concentrations of nanomaterials. A gap exists between existing particle measurement 
methods and those truly appropriate for nanoaerosol exposure assessment. Until now, the 
primary tools available for measurement of nano-sized aerosols have been Condensation 
Particle Counters (CPCs), and Differential Mobility Analyzers (DMA). Results of the 
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particle counting detection efficiency of the Condensation Particle Counter TSI CPC 
3762 for different operating parameters have been presented (Banse et al. 2001). This 
study showed a substantial decrease in the efficiency in the range of particle diameter of 
6-10 nm. DMA measurements suffer mainly due to the low probability with which in this 
range of sizes nanoparticles are charged (NSF, 2003). Even with improved aerosol 
instrumentation for nano-sized particles, the issues of respiratory tract deposition 
quantitation cannot be resolved without a direct localized measurement of particle dose.  
 
The experiments at PSI and the measurements on miners serve as a model for 
experiments that can be performed in laboratory conditions. These experiments can 
provide accurate data on human breathing characteristics, deposition, lung dosimetry, and 
the assessment of true efficiency of respirators. 
 
A new instrument on the market, the Nanoparticle Surface Area Monitor (TSI 3550, 
Nanoparticle Surface Area Monitor, 2005), is used for assessment of deposited surface 
area (DSA) in the lung. Lung deposition estimates from this instrument are based on 
correlations developed (Wilson et al., 2004) between the electrical signal and modeled 
DSA. The instrument is said to be capable of detecting particles with diameters down to 
10 nm.  Another attempt to solve the problem of surface area assessment, previously 
presented (Maynard, 2003), is based on simultaneous number and mass concentration 
measurements.  
 
In addition to scrutinizing risks associated with exposure to radiation in these 
experiments, risks associated with exposure of nanometer sized particles must also be 
considered.  In the case of PSI experiments, we can calculate the concentration of the 1 
nm radon progeny, using data for concentration of the unattached fraction, which was 
3800 Bq/m3.  
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 According to the equation for radioactive decay: 
(dN/dt) =   λ*N          
where dN/dt  is activity in Bq (decay per seconds),  
λ  is a decay constant, and  
N is the number of atoms.   
 
For 218Po,  λA= 3.788*10-3 s-1. At a concentration of 3800 Bq/m3 the number 
concentration of 1 nm particles will be approximately 106 m-3, or 1 cm-3, which is an 
extremely low aerosol concentration.  If expressed in mass concentration units, it will be 
around 10-9 µg/m3, again extremely small in comparison with 10 µg/m3 as discussed by 
Oberdöster for carbon nanotubes and C60 (Oberdöster et al., 2005).  Of course, with these 
data, only for air concentration, it is not possible to calculate the true dose for target cells 
in the respiratory system in terms of the density of the number of particles per cm2, 
especially because results from modeling (Balásházy, 2000) showed that such particles 
can form “hot spots” , i.e. extremely high local density of particles. 
 
Clearly, all human experiments with nanometer particles labeled with radioactive 
markers need careful consideration from the point of view of both radioactive and non-
radioactive nanometer aerosols safety.  Still, in the balance, the scientific need for 
information from good human lung dosimetry experiments suggest that the problem 
should be considered. 
 
From these observations, the following conclusions can be made: 
 
1.  Radon decay products (as a radioactive marker) can be used in a controlled manner 
that provides minimal risk in human studies under laboratory conditions.  
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2.  Particle deposition, lung dosimetry, measurement of the breathing characteristics, and 
respirator efficiency for nanometer sized particles may be measured by non-invasive 
techniques under laboratory conditions, in the range of exposures described in this 
paper. 
3.  The unattached fraction of radon progeny can be used for quantitative assessment of a 
very important characteristic of nanometer-sized aerosols, that is, the aerosol particle 
surface area.  
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FIGURE CAPTIONS 
Figure 1. 226Ra Family depicting the chain of decay products and particle emissions. 
Figure 2. Instrument for Filtration Ability of Lung (FAL) measurement. 1 – NaI detector; 
2 – collimators; 3 – lead shield; 4 – air sample. 
Figure 3. Basic processes of Rn decay product behavior in air defining “unattached” and 
“aerosol-attached” activities. 
Figure 4. Unattached fraction of 218Po, f vs. aerosol surface area concentrations. 
 
Figure 5. Relationship between particle surface area and particle radius. 
Figure 6. Relationship between particle surface area and unattached fraction
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TABLES 
Table 1. Measured Air Concentration of 214Pb and 214Bi, Gamma Ray Activity in Miners' Lungs and Calculated Filtration Ability of 
Lungs (FAL) for Different Groups of Miners in a Metal Mine in Tajikistan   
Job # of Air Concentration of Activity in Lungs (kBq)a FAL=vk (m3.min-1) FALmeans/FALstdb
Category 
  
Samples 
 
214Pb+214Bi (kBq.m-3)  
  Average   Std     Median # lung       Average     Std Median   Average     Std     Median   Average    Median 
                    error measurements          error 
 
                    error 
 
 
    
Drilling 92  5.92       0.55         3.7    21            2.66         0.22       2.59 0.0079      0.0014    0.0090      1.6              1.8 
Auxiliary 76  6.88        0.81        5.2  104            2.63         0.30      1.92 0.0067      0.0015   0..0062    1.3              1.25 
Inspection    129 
 
   11.1       1.11            7.4 
 
   68            3.26         0.33      2.11 
 
0.0052      0.0011    0.0055     
 
  1.4              1.1 
 Personnel  
      
Average       8.9          0.9           5.2                      2.85           0.26    2.22     0.0066      0.0011 0.0069      1.4              1.4 
a Actual gamma activities at time of measurement.  In calculating FAL a correction was made on Aγ to account for decay between 
end of shift and time of measurement, in all cases less than 1 h. 
b FAL means is the value based on measured data, FAL std is the calculated value based on assumed standard breathing rate of 0.020 
m3.min-1 and standard fractional lung deposition of 0.25.
FIGURES 
 
 
Figure 1. 226Ra Family depicting the chain of decay products and particle emissions. 
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Figure 2. Instrument for Filtration Ability of Lung (FAL) measurement. 1 – NaI detector 
2 – collimators; 3 – lead shield; 4 – air sample. 
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Figure 3. Basic processes of Rn decay product behavior in air defining “unattached” and 
“aerosol-attached” activities. 
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Figure 4. Unattached fraction of 218Po, f vs. aerosol surface area concentrations. 
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Figure 5. Relationship between particle surface area and particle radius. 
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Figure 6. Relationship between particle surface area and unattached fraction 
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